Christopher J. Yarnold

Potent and Selective Inhibition of Varicella-Zoster Virus (VZV) by Nucleoside Analogues with an Unusual Bicyclic Base

Christopher McGuigan, Christopher J. Yarnold, Garry Jones et al. · Journal of Medicinal Chemistry · 1999 · 187 citations

Lead Compounds, New Category, Medicinal Chemistry +15

Discovery and Structure–Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington’s Disease

Michael E. Prime, Ole A. Andersen, John J. Barker et al. · Journal of Medicinal Chemistry · 2012 · 69 citations · Full text

Structure–activity Relationship, Biochemistry, G Protein-coupled Receptor +12

Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease

Leticia Toledo‐Sherman, Michael E. Prime, Ladislav Mrzljak et al. · Journal of Medicinal Chemistry · 2015 · 61 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Neurodegenerative Diseases +15

Discovery of a Novel Hsp90 Inhibitor by Fragment Linking

John J. Barker, Oliver Barker, Stephen M. Courtney et al. · ChemMedChem · 2010 · 50 citations

Protein Function, Fragment Hits, Biochemistry +11

Fragment‐based Identification of Hsp90 Inhibitors

John J. Barker, Oliver Barker, Roberto Boggio et al. · ChemMedChem · 2009 · 47 citations

Drug Target, Structural Bioinformatics, Molecular Biology +17